Series A - Stem Cell Theranostics

Series A - Stem Cell Theranostics

Investment Firm

Overview

Accelerating therapeutic discovery and enabling personalized medicine through the use of patient-derived cell models

Announced Date

Jan 01, 2014

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Bill Marcus

Bill Marcus

Bill Marcus is a seed firm.

Participant Investors

1

Investor Name
Participant InvestorBill Marcus

Round Details and Background

Stem Cell Theranostics raised $5500000 on 2014-01-01 in Series A

Accelerating therapeutic discovery and enabling personalized medicine through the use of patient-derived cell models

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 17, 2015
Grant - Stem Cell Theranostics
1-150.0K
Jan 01, 2014
Series A - Stem Cell Theranostics
1-5.5M

Recent Activity

There is no recent news or activity for this profile.